IFNA1 and neoplasm: The effects on IFN signaling observed at the 24-hour time point were largely abrogated in the late cohort (≥72 hours), with the notable exception of one patient sample (patient 13; lip/chin tumor, local disease; HPV status, negative; smoking status, previous) that had sustained expression of ISG15 at clearly discernible sites exposed to dazostinag alone and in all triple combination sites (Supplementary Fig. S6).